Donation Activities and Product Integrity in Unrelated Donor Allogeneic Hematopoietic Transplantation: Experience of the National Marrow Donor Program

Phase II Study of Mega-Dose 90Y-Ibritumomab Tiuxetan, Fludarabine and Low-Dose TBI Followed By Allogeneic Hematopoietic Transplantation for Relapsed or Refractory Aggressive Large B-Cell Lymphoma: Long-Term Outcomes

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00510-8 ◽

2021 ◽

Vol 27 (3) ◽

pp. S395-S396

Author(s):

Victor A. Chow ◽

Ryan D. Cassaday ◽

Ted A. Gooley ◽

Brenda M. Sandmaier ◽

Stephen D. Smith ◽

...

Keyword(s):

Low Dose ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Long Term Outcomes ◽

Ibritumomab Tiuxetan ◽

Large B Cell Lymphoma ◽

Infliximab for the Treatment of Severe Steroid Refractory Acute Graft-versus-host Disease in Three Patients after Allogeneic Hematopoietic Transplantation

Leukemia & Lymphoma ◽

10.1080/1042819031000123483 ◽

2003 ◽

Vol 44 (12) ◽

pp. 2095-2097 ◽

Cited By ~ 24

Author(s):

Takahisa Yamane ◽

Ryousuke Yamamura ◽

Yasutaka Aoyama ◽

Hirohisa Nakamae ◽

Taro Hasegawa ◽

...

Keyword(s):

Graft Versus Host Disease ◽

Host Disease ◽

Graft Versus Host ◽

Steroid Refractory ◽

Acute Graft

Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups

Bone Marrow Transplantation ◽

10.1038/s41409-021-01252-7 ◽

2021 ◽

Author(s):

Marie Robin ◽

Raphael Porcher ◽

Corentin Orvain ◽

Jacques-Olivier Bay ◽

Fiorenza Barraco ◽

...

Keyword(s):

Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia

Current Opinion in Immunology ◽

10.1016/j.coi.2009.07.015 ◽

2009 ◽

Vol 21 (5) ◽

pp. 525-530 ◽

Cited By ~ 93

Author(s):

Andrea Velardi ◽

Loredana Ruggeri ◽

Antonella Mancusi ◽

Franco Aversa ◽

Frank T Christiansen

Keyword(s):

Natural Killer Cell ◽

Natural Killer ◽

Killer Cell ◽

Missing Self ◽

Pushing the envelope—nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation

Bone Marrow Transplantation ◽

10.1038/bmt.2015.61 ◽

2015 ◽

Vol 50 (9) ◽

pp. 1157-1167 ◽

Cited By ~ 14

Author(s):

S R Pingali ◽

R E Champlin

Keyword(s):

Reduced Intensity

Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria

Haematologica ◽

10.3324/haematol.2018.198549 ◽

2019 ◽

Vol 104 (8) ◽

pp. 1682-1688 ◽

Cited By ~ 36

Author(s):

Giorgia Battipaglia ◽

Florent Malard ◽

Marie Therèse Rubio ◽

Annalisa Ruggeri ◽

Anne Claire Mamez ◽

...

Keyword(s):

Multidrug Resistance ◽

Fecal Microbiota Transplantation ◽

Hematologic Malignancies ◽

Fecal Microbiota ◽

Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the Duet™ (BioView) combined morphological and cytogenetical analysis

Leukemia ◽

10.1038/sj.leu.2402604 ◽

2002 ◽

Vol 16 (8) ◽

pp. 1419-1422 ◽

Cited By ~ 8

Keyword(s):

Minimal Residual Disease ◽

Residual Disease ◽

Cytogenetical Analysis ◽

Minimal Residual

T-Cell Engraftment Kinetics Following Myeloablative and Nonmyeloablative Regimens for Allogeneic Hematopoietic Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2008.12.313 ◽

2009 ◽

Vol 15 (2) ◽

pp. 102

Author(s):

D. Mickelson ◽

L. Sproat ◽

R. Dean ◽

R. Sobecks ◽

L. Rybicki ◽

...

Keyword(s):

T Cell ◽

Cell Engraftment ◽

Is unrelated donor or haploidentical hematopoietic transplantation preferred for patients with acute myeloid leukemia in remission?

Haematologica ◽

10.3324/haematol.2019.239624 ◽

2020 ◽

Vol 105 (2) ◽

pp. 252-254 ◽

Cited By ~ 2

Author(s):

Richard Champlin

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Unrelated Donor ◽

Acute Myeloid

Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment and Length of Hospitalization in Myeloablative Allogeneic Hematopoietic Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.355 ◽

2019 ◽

Vol 25 (3) ◽

pp. S283

Author(s):

Craig Freyer ◽

Alex Ganetsky ◽

Colleen Timlin ◽

Daria Babushok ◽

Noelle V. Frey ◽

...

Keyword(s):

Host Disease ◽

Graft Vs Host Disease ◽

Length Of Hospitalization ◽

Neutrophil Engraftment